HPTN Publications

Salomon EA, Mimiaga MJ, Husnik MJ, Welles SC, Manseau MW, Montenegro AB, Safren SA, BA Koblin, Chesney MA, Mayer KH . Depressive Symptoms, Utilization of Mental Health Care, Substance Use and Sexual Risk Among Young Men Who have Sex with Men in EXPLORE: Implications for Age-Specific Interventions. AIDS Behav. 2009, 13: 811-821 PMCID: 2718068
Sánchez J, Sal Y Rosas VG, Hughes JP, Baeten JM, Fuchs J, Buchbinder SP, Koblin BA, Casapia M, Ortiz A, Celum C . Male circumcision and risk of HIV acquisition among men who have sex with men. AIDS. 2010, 25: 519-23 PMCID: 3120051
Schachterle SE, Mtove G, Levens JP, Clemens EG, Shi L, Raj A, Munoz B, Reller ME, West S, Dumler JS, Sullivan D; PRET Project Team . Prevalence and density-related concordance of three diagnostic tests for malaria in a region of Tanzania with hypoendemic malaria. J Clin Microbiol. 2011, 49: 3885-91 PMCID: 3209109
Schackman BR, Eggman AA, Leff JA, Braunlin M, Felsen UR, Fitzpatrick L, Telzak EE, El-Sadr W, Branson BM . Costs of Expanded Rapid HIV Testing in Four Emergency Departments. Public Health Rep. 2016, 131 Suppl 1: 71-81
Schechter M, do Lago RF, de Melo MF, Sheppard HW, Guimaraes NC, Moreira RI, Faulhaber JC, Batista S, Harrison LH . Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil. Projeto Praca Onze Study Group.. Acquir Immune Defic Syndr. 2000, 24: 175-7
Schreiber CA, Sammel M, Hillier SL, Barnhart KT . A Little Bit Pregnant: Modeling How the Accurate Detection of Pregnancy Can Improve HIV Prevention Trials. Am J Epidemiol. 2009, 169: 515-21 PMCID: 2732971
Schreiber CA, Whittington S, Cen L, Maslankowski L . Good intentions: risk factors for unintended pregnancies in the US cohort of a microbicide trial. Contraception. 2011, 83: 74-81 PMID:21134507
Seage GR 3rd, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP . Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol. 2001, 153: 619-27
Shaboltas AV, Toussova OV, Hoffman IF, Heimer R, Verevochkin SV, Ryder RW, Khoshnood K, Perdue T, Masse BR, Kozlov AP . HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. JAIDS. 2006, 41: 657-63 PMID: 16652041
Shafer RW, Chaung T, Hsu P, White CB, Katzenstein DA . Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. AIDS Res Hum Retroviruses. 1999, 15: 65-9
Shanaube K, Schaap A, Floyd S, Phiri M, Griffith S, Chaila MJ, Peter Bock, Hayes R, Fidler S, Ayles H, on behalf of the HPTN 071 (PopART) Study Team . What Works-Reaching Universal HIV testing: Lessons from HPTN 071 (PopART) trial in Zambia. AIDS. 2017, 2017
Sheppard HW, Celum CL, Michael NL, O'Brien S, Dean M, Carrington M, Dondero D, Buchbinder SP . HIV-1 infection in individuals with the CCR5-delta32/delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr. 2002, 29: 307-13
Shetty AK, Coovadia HM, Mirochnick MM, Maldonado Y, Mofenson LM, Eshleman SH, Fleming T, Emel L, George K, Katzenstein DA, Wells J, Maponga CC, Mwatha A, Jones SA, Abdool Karim SS, Bassett MT . Safety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants From Birth to 6 Months. J Acquir Immune Defic Syndr. 2003, 34: 482-90
Shoptaw S, Montgomery B, Williams CT, El-Bassel N, Aramrattana A, Metsch L, Metzger DS, Kuo I, Bastos FI, Strathdee SA . Not just the needle: the state of HIV-prevention science among substance users and future directions. J Acquir Immune Defic Syndr. 2012, 63: S174-8 PMCID: 3739052
Silverthorn CF, Parsons TL . A validated new method for nevirapine quantitation in human plasma via high-performance liquid chromatography. Biomed Chromatogr. 2006, 20: 23-7 PMID: 15920701
Simwinga M, Bond V, Makola N, Hoddinott G, Belemu S, White R, Shanaube K, Seeley J, Moore A . Implementing Community Engagement for Combination Prevention: Lessons Learnt From the First Year of the HPTN 071 (PopART) Community-Randomized Study. Curr HIV/AIDS Rep. 2016
Sinkala M, Stout JP, Vermund SH, Goldenberg RL, Stringer JSA . Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV. Lancet. 2001, 358: 1611-12
Sista ND, Abdool Karim Q, Hinson K, Donnell D, Eshleman SH, Vermund SH . Experience in international clinical research: the HIV Prevention Trials Network. Clin Invest. 2011, 1: 1609-18 PMCID: 3281583
Sithole B, Mbhele L, Van Rooyen H, Khumalo-Sakutukwa G, Richter L . Only skin deep: limitations of public health understanding of male circumcision in South Africa. S Afr Med J. 2009, 99: 647 PMCID: 2861782
Sivay MA, Zhang Y, Hudelson SE, Li M, Piwowar-Manning E, Marzinke MA, Bokoch K, Grant RM, Eshleman SH . Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067. J Acquir Immune Defic Syndr. , 75: 271-279
Smita J, Soma D, Beverly B, Albert P, JoAnn K, Fang G, Missy C, Lydia ST, Anjali P, Arun R, Sanjay M, Steven J R; HIV Prevention Trial Network HPTN 047 Protocol Team . Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India. AIDS Res Ther (Epub). 2006, 3: 4 PMCID: 1435917
Smith MK, Rutstein SE, Powers KA, Fidler S, Miller WC, Eron JJ Jr, Cohen MS . The detection and management of early HIV infection: a clinical and public health emergency. J Acquir Immune Defic Syndr. 2013, 63: S187-99 PMCID: 4015137
Smith, L. R., Strathdee, S. A., Metzger, D., Latkin, C. . Evaluating network-level predictors of behavior change among injection networks enrolled in the HPTN 037 randomized controlled trial. Drug Alcohol Depend. 2017, 175: 164-170
Solomon S, Buck J, Chaguturu SK, Ganesh AK, Kumarasamy N . Stopping HIV before it begins: issues faced by women in India. Nat Immunol. 2003, 4: 719-21
Solomon SS, Solomon S, Masse BR, Srikrishnan AK, Beauchamp G, Thamburaj E, Gulvady M, Anand S, Mayer KH . Risk reduction counseling is associated with decreased HIV transmission-associated behaviors in high-risk Indian heterosexuals. J Acquir Immune Defic Syndr. 2006, 42: 478-83 PMID: 16763526
Spielberg F, Critchlow C, Vittinghoff E, Coletti AS, Sheppard H, Mayer KH, Metzgerg D, Judson FN, Buchbinder S, Chesney M, Gross M . Home collection for frequent HIV testing: acceptability of oral fluids, dried blood spots and telephone results. HIV Early Detection Study Group. AIDS. 2000, 14: 1819-28
Spielberg F, Critchlow C, Vittinghoff E, Gross M, Doherty-Iddings P, Scotti R, Judson FN, Marmor M, Buchbinder S . Slow diffusion of home HIV-specimen collection: provider concerns at odds with client preferences. Sex Transm Dis. 2001, 28: 51-7
Srikrishnan AK, Hendriksen E, Vallabhaneni S, Johnson SL, Raminani S, Kumarasamy N, Hobsen J, Solomon S, Mayer KH, Safren SA . Sexual behaviors of individuals with HIV living in South India: a qualitative study. AIDS Educ Prev. 2007, 19: 334-45
Srikrishnan AK, Venkatesh K, Solomon S, Thamburaj E, Anand S, Kosalaraman KG, Balakrishnan P, Mayer K . Expansion of HIV Laboratory Diagnostic Services in Chennai, India 2001-2006: Is the Growth Commensurate with the Need?. PLoS One. 2008, 3: e3471 PMCID:2565796
Stephenson J . Health agencies update: HIV Prevention Trials Network. JAMA. 2000, 284: 822
Stone E, Heagerty P, Vittinghoff E, Douglas JM, Koblin BA, Mayer KH, Celum CL, Gross M, Woody GE, Marmor M, Seage GR, Buchbinder SP, Douglas JM Jr, Seage GR 3rd . Correlates of condom failure in a sexually active cohort of men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol. 1999, 20: 495-501
Straseski JA, Stolbach A, Clarke W . Opiate-positive immunoassay screen in a pediatric patient. Clin Chem. 2010, 56: 1220-3 PMCID: 2975969
Stringer E, Read JS, Hoffman I, Valentine M, Aboud S, Goldenberg RL . Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth. S Afr Med J. 2010, 100: 58-64 PMCID: 3090676
Stringer EM, Sinkala M, Kumwenda R, Chapman V, Mwale A, Vermund SH, Goldenberg RL, Stringer JS . Personal risk perception, HIV knowledge and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric population. J Acquir Immune Defic Syndr. 2004, 35: 60-6
Stringer JS, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett AA . Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2000, 24: 369-77
Stringer JS, Sinkala M, Chapman V, Acosta EP, Aldrovandi GM, Mudenda V, Stout JP, Goldenberg RL, Kumwenda R, Vermund SH . Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS. 2003, 17: 1659-65
Stringer JS, Sinkala M, Goldenberg R, Vermund S, Acosta E . Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1. Lancet. 2003, 362: 667
Stringer JS, Sinkala M, Goldenberg RL, Kumwenda R, Acosta EP, Aldrovandi GM, Stout JP, Vermund SH . Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. AIDS. 2004, 18: 939-43
Stringer JS, Sinkala M, Rouse DJ, Goldenberg RL, Vermund SH . Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health. 2002, 92: 365-6
Sucato G, Celum CL, Dithmer D, Ashley RL, Wald A . Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescehts. Pediat Infect Dis. 2001, 20: 422-6
Sugarman J, Corneli A, Donnell D, Liu TY, Rose S, Celentano D, Jackson B, Aramrattana A, Wei L, Shao Y, Liping F, Baoling R, Dye B, Metzger D . Are there adverse consequences of quizzing during informed consent for HIV research?. J Med Ethics. 2011, 37: 693-7 PMCID: 3200567
Sugarman J, Grace WC . Ethics and the standards of prevention in HIV prevention trials - comment. AIDS. 2010, 24: 2298-9 PMID:20736687
Sugarman J, Mayer KH . Ethics and pre-exposure prophylaxis for HIV infection. J Acquir Immune Defic Syndr. 2013, 63: S135-9 PMCID: 3728665
Sugarman J, Rose SM, Metzger D . Ethical issues in HIV prevention research with people who inject drugs. Clin Trials. 2014, 11: 239-45
Sugarman J, Stalter R, Bokoch K, Liu T, and Donnell D, Donnell D . Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs. IRB: Ethics & Human Research. 2015, 37: 17-19
Susan H Eshleman, Estelle Piwowar-Manning, Mariya V. Sivay, Barbara Debevec, Stephanie Veater, Laura McKinstry, Linda Gail Bekker, Sharon Mannheimer, Robert M. Grant, Margaret A. Chesney, Thomas J. Coates, Beryl A. Koblin, Jessica M. Fogel . Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection.. J Clin Virol. , 99-100: 67-70
Sweat M, Morin S, Celentano D, Mulawa M, Singh B, Mbwambo J, Kawichai S, Chingono A, Khumalo-Sakutukwa G, Gray G, Richter L, Kulich M, Sadowski A, Coates T . Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infectious Disease. 2011, 11: 525-32 PMCID: 3156626
T Gamble, B Branson, D Donnell, HI Hall, G King, B Cutler, S Hader, D Burns, J Leider, AF Wood, KG Volpp, WM El-Sadr . Design of the HPTN 065 (TLC-Plus) Study: A Study to Evaluate the Feasibility of an Enhanced Test, Link-to-Care, Plus Treat Approach for HIV Prevention in the United States. Clin Trials. 2017, 14: 322-332
Tabet S, Sanchez J, Lama J, Goicochea P, Campos P, Rouillon M, Cairo JL, Ueda L, Watts D, Celum C, Holmes K . HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. AIDS. 2002, 16: 1271-1277
Tabet SR, Callahan MM, Mauck CK, Gai F, Coletti AS, Profy AT, Moench TR, Soto-Torres LE, Poindexter AN, Frezieres RG, Walsh TL, Kelly CW, Richardson BA, van Damme L, Celum CL . Safety and Acceptability of Penile Application of 2 Candidate Topical Microbicides: BufferGel and PRO 2000 Gel: 3 Randomized Trials in Healthy Low-Risk Men and HIV-Positive Men. J Acquir Immune Defic Syndr. 2003, 33: 476-83
Tabet SR, Surawicz C, Horton S, Paradise M, Coletti AS, Gross M, Fleming TR, Buchbinder S, Haggitt RC, Levine H, Kelly CW, Celum CL . Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. Sex Transm Dis. 1999, 26: 564-71
Taha TE, Brown ER, Hoffman IF, Fawzi W, Read JS, Sinkala M, Martinson FE, Kafulafula G, Msamanga G, Emel L, Adeniyi-Jones S, Goldenberg R . A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS. 2006, 20: 1313-21 PMID: 16816561
Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, Liomba GN, Kumwenda NI, Miotti PG . Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS. 1998, 12: 197-203
Taha TE, Graham SM, Kumwenda NI, Broadhead RL, Hoover DR, Markakis D, van Der Hoeven L, Liomba GN, Chiphangwi JD, Miotti PG . Morbidity among human immunodeficiency virus-1-infected and -uninfected African children. Pediatrics. 2000, 106: E77
Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG . Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998, 12: 1699-706
Taha TE, Hoover DR, Kumwenda NI, Fiscus SA, Kafulafula G, Nkhoma C, Chen S, Piwowar E, Broadhead RL, Jackson JB, Miotti PG . Late postnatal transmission of HIV-1 and associated factors. J Infect Dis. 2007, 196: 10-14 PMID: 17538877
Taha TE, James MM, Hoover DR, Sun J, Laeyendecker O, Mullis CE, Kumwenda JJ, Lingappa JR, Auvert B, Morrison CS, Mofensen LM, Taylor A, Fowler MG, Kumenda NI, Eshleman SH . Association of recent HIV infection and in-utero HIV-1 transmission. AIDS. 2011, 25: 1357-1364 PMCID: 3263827
Taha TE, Kumwenda N, Gibbons A, Hoover D, Lema V, Fiscus S, Mukiibi J, Liomba G, Broadhead R . Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants. AIDS. 2002, 16: 851-8
Taha TE, Kumwenda NI, Hoover DR, Biggar RJ, Broadhead RL, Cassol S, van der Hoven L, Markakis D, Liomba GN, Chiphangwi JD, Miotti PG . Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age. AIDS. 2000, 14: 453-9
Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, Nour S, Chen S, Liomba G, Miotti PG, Broadhead RL . Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting; a randomized controlled trial. JAMA. 2004, 292: 202-9
Taha TE, Kumwenda, Broadhead, Hoover, Graham, Hoeven, LV, D, Markakis, Liomba, GN, Chiphangwi, JD, Miotti, PG, Kumwenda NI, Broadhead RL, Hoover DR, Graham SM, Van Der Hoeven . Mortality after the first year of life among HIV infected and uninfected children. Ped Infect Dis J. 1999, 18: 689-94
Tedrow VA, Zelaya CE, Kennedy CE, Morin SF, Khumalo-Sakutukwa G, Sweat MD, Celentano DD . No "Magic Bullet": Exploring community mobilization strategies used in a multi-site community based randomized controlled trial: Project Accept (HPTN 043). AIDS Behav. 2012, 16: 1217-26 PMCID: 3400971
Thompson CG, Cohen MS, Kashuba AD . Antiretroviral pharmacology in mucosal tissues. J Acquir Immune Defic Syndr. 2013, 63: S240-7 PMCID:3951793
Tien PC, Chiu T, Latif AS, Ray S, Batra M, Contag CH, Zejenah L, Mbizvo M, Delwart EL, Mullins JI, Katzenstein DA . Primary subtype C HIV-1 infection in Harare, Zimbabwe. J Acquir Immune Defic Syndr Hum Retrovirol. 1999, 20: 147-53
Tieu HV, Liu TY, Hussen S, Connor M, Wang L, Buchbinder S, Wilton L, Gorbach P, Mayer K, Griffith S, Kelly C, Elharrar V, Phillips G, Cummings V, Koblin B, Latkin C; HPTN 061 . Sexual Networks and HIV Risk among Black Men Who Have Sex with Men in 6 U.S. Cities. PLoS One. 2015, 10: e0134085
Tieu HV, Rolland M, Hammer SM, Sobieszczyk ME . Translational research insights from completed HIV vaccine efficacy trials. J Acquir Immune Defic Syndr. 2013, 63: S150-4
Tobian AA, Gaydos C, Gray RH, Kigozi G, Serwadda D, Quinn N, Grabowski MK, Musoke R, Ndyanabo A, Nalugoda F, Wawer MJ, Quinn TC . Male circumcision and Mycoplasma genitalium infection in female partners: a randomised trial in Rakai, Uganda. Sex Transm Infect. 2014, 90: 150-4
Towler WI, Barlow-Mosha L, Church JD, Bagenda D, Ajuna P, Mubiru M, Musoke P, Eshleman SH . Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. AIDS Res Hum Retroviruses. 2010, 26: 563-8 PMCID: 2875950
Towler WI, Church JD, Eshleman JR, Fowler MG, Guay LA, Jackson JB, Eshleman SH . Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq). AIDS Res Hum Retroviruses. 2008, 24: 1209-13. PMCID:2562759
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson JB, Eshleman SH . Analysis of HIV diversity using a high-resolution melting assay. AIDS Res Hum Retroviruses. 2010, 26: 913-8 PMCID: 2920076
Valsamakis A . Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev. 2007, 20: 426-39
van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson K . Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr. 2001, 26: 21-7
Van Der Pol B, Williams JA, Taylor SN, Cammarata CL, Rivers CA, Body BA, Nye M, Fuller D, Schwebke JR, Barnes M, Gaydos CA . Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system. J Clin Microbiol. 2014, 52: 885-9
van Rooyen H, McGrath N, Chirowodza A, Joseph P, Fiamma A, Gray G, Richter L, Coates T . Mobile VCT: Reaching Men and Young People in Urban and Rural South African Pilot Studies (NIMH Project Accept, HPTN 043). AIDS Behav. 2013, 17: 2946-53 PMCID: 3597746
Venkatesh KK, Madiba P, De Bruyn G, Lurie MN, Coates TJ, Gray GE . Who gets tested for HIV in a South African urban township? Implications for test and treat and gender-based prevention interventions. JAIDS. 2011, 56: 151-65 PMCID: 3137901
Vermund SH, Fidler SJ, Ayles H, Beyers N, Hayes RJ. . Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia. J Acquir Immune Defic Syndr. 2013, 63: S221-7 PMCID: 3739051
Vermund SH, Hodder SL, Justman JE, Koblin BA, Mastro TD, Mayer KH, Wheeler DP, El-Sadr WM . Addressing research priorities for prevention of HIV infection in the United States. Clin Infect Dis. 2010, 50: S149-55 PMCID: 2862583
Viljoen L, Ndubani R, Bond V, Seeley J, Reynolds L, Hoddinott G, on behalf of the HPTN 071 (PopART) Study Team . Community narratives about women and HIV risk in 21 high-burden communities in Zambia and South Africa (HPTN 071). J Womens Health. 2017, 9: 861—870
Wada NI, Jacobson LP, Margolick JB, Breen EC, Macatangay B, Penugonda S, Martinez-Maza O, Bream JH . The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. 2015, 29: 463-71
Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCauley M, Gamble T, Seage GR 3rd, Cohen MS, Freedberg KA. . Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. NEJM. 2013, 369: 1715-25 PMCID: 3913536
Watson-Jones D, Wald A, Celum C, Lingappa J, Weiss HA, Changalucha J, Baisley K, Tanton C, Hayes RJ, Marshak JO, Gladden RG, Koelle DM . Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol. 2010, 48: 3496-503 PMCID: 2953087
Watts DH, Brown ER, Maldonado Y, Herron C, Chipato T, Reddy L, Moodley D, Nakabiito C, Manji K, Fawzi W, George K, Richardson P, Zwerski S, Coovadia H, Fowler M; HPTN 046 Protocol Team . HIV Disease Progression in the First Year After Delivery Among African Women Followed in the HPTN 046 Clinical Trial. J Acquir Immune Defic Syndr. 2013, 64: 299-306 PMCID: 3800257
Wei L, Chen J, Rodolph M, Beauchamp G, M 0226 Sse B, Li R, Wang S, Ruan Y, Lai S, Zhang L, Zhou F, Rose SM, Perdue T, Shao Y, Jackson JB . HIV Incidence, Retention, and Changes of High-Risk Behaviors Among Rural Injection Drug Users in Guangxi, China. Subst Abus. 2006, 274: 53-61 PMID: 17347126
Welte A, McWalter TA, Laeyendecker O, Hallet TB . Using tests for recent infection to estimate incidence: Problems and Prospects for HIV. Euro Surveill. 2010, 15: pii: 19589 PMCID: 2937566
Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Brookmeyer R, Quinn TC, Laeyendecker O . Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection. PLoS One. 2013, 8: e55525 PMCID: 3577851
Westheimer EF, Urassa W, Msamanga G, Baylin A, Wei R, Aboud S, Kaaya S, Fawzi WW . Acceptance of HIV Testing Among Pregnant Women in Dar-es-Salaam, Tanzania. J Acquir Immune Defic Syndr. 2004, 37: 1197-1205
Williams C, Eisenberg M, Becher J, Davis-Vogel A, Fiore D, Metzger D . Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks. J Acquir Immune Defic Syndr. 2013, 63: S90-4 PMCID: In Process
Williams JK, Wilton L, Magnus M, Wang L, Wang J, Dyer TP, Koblin BA, Hucks-Ortiz C, Fields SD, Shoptaw S, Stephenson R, O'Cleirigh C, Cummings V; HIV Prevention Trials Network 061 Study Team . Relation of Childhood Sexual Abuse, Intimate Partner Violence, and Depression to Risk Factors for HIV Among Black Men Who Have Sex With Men in 6 US Cities. Am J Public Health. 2015, 105: 2473-81
Wilson CM, Gray G, Read JS, Mwatha A, Lala S, Johnson S, Violari A, Sibiya PM, Fleming TR, Koonce A, Vermund SH, McIntyre J . Tolerance and Safety of Different Concentrations of Chlorhexidine for Peripartum Vaginal and Infant Washes: HIVNET 025. J Acquir Immune Defic Syndr. 2004, 35: 138-43
Wilson SE, Pedersen SL, Kunich JC, Wilkins VL, Mann DL, Mazzara GP, Tartaglia J, Celum CL, Sheppard HW . Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. AIDS Res Hum Retroviruses. 1998, 14: 925-37
Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, Siliciano JD, Quinn TC, Siliciano RF . Identification of Nevirapine-Resistant HIV-1 in the Latent Reservoir after Single-Dose Nevirapine to Prevent Mother-to-Child Transmission of HIV-1. J Infect Dis. 2009, 199: 1301-9 PMCID:2703715
WM El-Sadr, D Donnell, G Beauchamp, HI Hall, LV Torian, B Zingman, G Lum, M Kharfen, R Elion, FM Gordin, V Elharrar, D Burns, A Zerbe, T Gamble, B Branson . Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065). 2017
Wong LH, Van Rooyen H, Modiba P, Richter L, Gray G, McIntyre JA, Schetter CD, Coates T . Test and Tell: Correlates and Consequences of Testing and Disclosure of HIV Status in South Africa (HPTN 043 Project Accept). JAIDS. 2009, 50: 215-22 PMCID:2729272
Woodsong C . Covert use of topical microbicides: implications for acceptability and use. Perspect Sex Reprod Health. 2004, 36: 127-31